سعر سوماجرين 100 مجم 2 قرص 2026

Sumatriptan oral tablets (triptan) listed in Egyptian price directories for acute migraine.

• Acute treatment of migraine with or without aura in adults (not for prevention; not established for cluster headache)Population: AdultsDailyMed (U.S. National Library of Medicine)

• Adverse reactions in placebo-controlled trials include paresthesia, warm/cold sensations, chest/neck/throat/jaw pain, tightness or pressure, and malaise/fatigue.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Ischemic coronary artery disease or coronary artery vasospasm, including Prinzmetal angina.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Wolff-Parkinson-White syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• History of stroke or transient ischemic attack, or hemiplegic or basilar migraine.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Serious cardiac events (myocardial ischemia/infarction, Prinzmetal angina, arrhythmias) can occur; evaluate patients with cardiovascular risk factors before use.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Serotonin syndrome may occur, particularly with SSRIs, SNRIs, TCAs or MAO inhibitors.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Significant blood pressure elevation, including hypertensive crisis, has been reported.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Ergot-containing drugsAdditive vasospastic effects; use within 24 hours is contraindicated.DailyMed (U.S. National Library of Medicine)
• MAO-A inhibitorsIncrease systemic exposure to sumatriptan; concurrent use or use within 2 weeks is contraindicated.DailyMed (U.S. National Library of Medicine)
• Other 5-HT1 agonists (triptans)Additive vasospastic effects; use within 24 hours of each other is contraindicated.DailyMed (U.S. National Library of Medicine)

• Pregnancy registry and epidemiological data have not detected an increased frequency or consistent pattern of birth defects; animal studies showed embryolethality and fetal abnormalities.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Sumatriptan is excreted in human milk after subcutaneous administration; infant exposure can be minimised by avoiding breastfeeding for 12 hours after treatment.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Sumatriptan: Agonist at 5-HT1B/1D receptors on intracranial blood vessels and trigeminal sensory nerves, causing cranial vessel constriction and inhibition of pro-inflammatory neuropeptide release (US label).